# CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

> **NCT02824874** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Duvie Tab. 0.5mg
- **DRUG:** Duvie Tab. 0.5mg + Januvia Tab. 100mg

## Key facts

- **NCT ID:** NCT02824874
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02824874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02824874, "CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02824874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*